Advertisement
The European Medicines Agency (EMA) on Thursday said it had started reviewing a Covid-19 jab by Franco-Austrian biotech firm Valneva, for which the EU has already signed a deal for 60 million doses.
“EMA’s human medicines committee has started a rolling review of VLA2001, a Covid-19 vaccine being developed by Valneva,” the regulator said in a statement, adding that it could not yet say when a decision on approval might come.
Advertisement
Advertisement
Read More News On
Catch all the International News, Breaking News Event and Latest News Updates on The BOL News
Download The BOL News App to get the Daily News Update & Follow us on Google News.